Stoke Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Stoke Therapeutics (STOK) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Stoke Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Stoke Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Stoke Therapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $660k | 28k | 23.50 |
| 2025-06-30 | $261k | 23k | 11.35 |
| 2025-03-31 | $118k | 18k | 6.65 |
| 2024-12-31 | $185k | 17k | 11.03 |
| 2024-09-30 | $137k | 11k | 12.29 |
| 2024-06-30 | $154k | 11k | 13.51 |
| 2024-03-31 | $133k | 9.9k | 13.50 |
| 2023-12-31 | $45k | 8.5k | 5.26 |
| 2023-09-30 | $27k | 6.8k | 3.94 |
| 2023-06-30 | $112k | 11k | 10.63 |
| 2022-12-31 | $923 | 100 | 9.23 |
| 2022-09-30 | $5.8k | 344 | 16.95 |
| 2022-06-30 | $7.9k | 575 | 13.79 |
| 2022-03-31 | $33k | 1.6k | 21.49 |
| 2021-12-31 | $193k | 8.0k | 24.03 |
| 2021-09-30 | $299k | 11k | 27.03 |
| 2021-06-30 | $169k | 5.0k | 33.62 |
| 2021-03-31 | $444k | 11k | 38.92 |
| 2020-12-31 | $497k | 8.0k | 61.89 |
| 2020-09-30 | $191k | 5.7k | 33.51 |
| 2020-06-30 | $245k | 10k | 23.85 |
| 2020-03-31 | $486k | 21k | 22.93 |
| 2019-12-31 | $510k | 18k | 28.30 |
| 2019-09-30 | $74k | 3.4k | 21.51 |